# Investigating the Effect of In Ovo Injection of Silver Nanoparticles on Fat Uptake and Development in Broiler and Layer Hatchlings

Authors: Lane Pineda; André Chwalibog; Ewa Sawosz; Anna Hotowy; Jan Elnif; Filip Sawosz
Journal: Journal of Nanotechnology
 (2012)

---

## Abstract

Silver nanoparticles (AgNano) as carrier of available oxygen (O2) and with high surface reactivity may increase O2 consumption, enhance fat uptake (FU), and stimulate growth and development. The objective was to investigate the effects of in ovo injection of AgNano on the metabolic rate (O2 consumption, CO2 production, and heat production, HP), fat uptake, and the development of broiler and layer hatchlings. AgNano concentrations (50, 75, and 100 mg/kg) were injected in ovo at day 1 of incubation to different breeds of broiler and layer chicken embryos. Oxygen consumption and subsequently FU did not increase linearly following AgNano treatment. FU was lower in hatchlings treated with 50 and 100 mg AgNano/kg, but surprisingly not in hatchlings treated with 75 mg AgNano/kg. Interestingly, the difference in FU between treatments was not reflected in hatchling development. The results indicated that AgNano affected metabolic rate and FU; however, it did not influence the development of hatchlings. This suggests that in ovo injection of AgNano reduces the need to use yolk fat as an energy source during embryonic development and consequently the remaining fat in the residual yolk sac may provide a potent source of nutritional reserves for chicks of few days after hatching.


---

## Body

## 1. Introduction

During the latter part of incubation, fat in the yolk provides the main source of energy for the developing embryo. Glucose from carbohydrates and protein provides an important source of energy during the first two weeks of embryonic development, and from then until 2 or 3 days before internal piping, fatty acids from the yolk supply 90% of the energy requirement of the embryo. Towards the end of incubation, a few days before piping, energy metabolism switches to glucose through gluconeogenesis and glycogenesis [1–3].Oxygen (O2) is an important factor for the effective retrieval of fat and β-oxidation of fatty acids from the yolk [1, 2]. In the developing embryo, starting at day 14, the chorioallantoic membrane mediates the transfer of O2 between the pores of the shell and the embryo [2, 4]. However, toward the end of incubation, O2 consumption reaches a plateau stage because of a restriction in the O2 diffusion capacity of the shell pore system. Consequently, the supply of O2 to the developing embryo becomes limited and the resultant hypoxia limits fat metabolism and eventually the growth of the embryo [5].Several techniques are under investigation to mitigate this effect and facilitate growth before and after hatching. In ovo nutrient supply, for example, is a technique that involves the injection of a nutrient solution few days prior to piping to provide an external source of energy to the embryo and to the hatchlings [3, 6]. The technique is very promising; however, the practice remains to be perfected and commercialised. Consequently, the development of other approaches needs to be considered.Recently, we reported that the metabolism of layer embryos can be modified with the in ovo injection of silver nanoparticles (AgNano) [7]. We demonstrated that AgNano at a concentration of 50 mg/kg, when injected in ovo at day 1 of incubation, increased the metabolic rate in layer embryos. However, in the previous experiment, this improvement in metabolic rate did not improve the growth of embryos. Therefore, the effect of different concentrations of AgNano was conducted via a dose-response experiment. This was to determine the optimum effective concentration of AgNano that will increase metabolic rate as well as improving the growth and development of broiler and layer chicken hatchlings. The study was extended to the determination of fat uptake in newly hatched chicks, considering that, in addition to genetic background; one factor for the growth difference between broiler and layer embryos is the rate of fat utilisation [8, 9]. Also, under practical conditions, hatchlings rely mainly on residual yolk sac components as an immediate source of nutrition for a few days after hatching until they receive an external source of nutrients [10]. We hypothesised that the introduction of AgNano capable of carrying O2 at the cellular level would offer an alternative approach in providing the O2 requirements of the developing embryo. Due to the high surface reactivity of AgNano, this treatment may promote the oxidation of fat in the yolk and subsequently fat uptake in hatchlings. The objectives of the study were to determine the effect of in ovo injection of AgNano on the metabolic rate (oxygen consumption, O2; carbon dioxide production, CO2; heat production), fat uptake, and the development of broiler and layer hatchlings.


## 2. Materials and Methods

### 2.1. Experimental Design

A 2 × 3 factorial experiment with two breeder strains (Ross × Ross 308 and Lohmann) and three AgNano concentrations (50, 75 and 100 mg/kg) was used.584 fertile chicken eggs from Lohmann (layer-type) and Ross × Ross 308 (broiler-type) breeder strains of the same age (37 weeks old) were obtained from a commercial hatchery. In each breeder strain, 292 eggs were randomly grouped into two batches and stored in a refrigerator (10°C) for 1–3 days before being placed in the incubator. In each batch, 140 eggs were distributed into 5 treatment groups, with 28 eggs per treatment from which 12 eggs from each treatment were used for the measurement of O2 consumption and CO2 production, 5 eggs for the evaluation of hatchling development, and the rest were used as reserves. In addition, 12 eggs per breeder strain were opened at day 1 and the yolk samples were collected. At day 1 of incubation, the eggs from the first batch were numbered and injected according to the following treatment descriptions: (1) control (no injection), (2) sham control (placebo), (3) 50 mg AgNano/kg, (4) 75 mg AgNano/kg, and (5) 100 mg AgNano/kg. The eggs were injected with 0.3 mL of a hydrocolloidal AgNano and phosphate buffered saline solution (placebo) into the air sac using a sterile 27 gauge, 20 mm needle. Immediately after injection, the hole was sealed with hypoallergenic tape and the eggs were placed into an incubator. The eggs were incubated for 21 days under standard conditions (temperature 37.8°C, 55% humidity, eggs turned once per hour for the first 18 days, and temperature 37°C, and 60% humidity from day 19 until hatching). The same procedure was repeated for the eggs in batch 2 on the following day.


### 2.2. Gas Exchange Measurement

The O2 consumption and CO2 production were measured at day 10, 13, 16, and 19 of incubation, according to the procedure described by Chwalibog et al. [11]. Gas exchange measurement was based on the paramagnetic principle in an open air circuit respiration unit (Micro-Oxymax calorimeter from Columbus Instruments, Columbus, OH, USA), equipped with four respiration chambers with a volume of 2000 cm3. The concentrations of O2 and CO2 in the incoming atmospheric air to the chambers were 20.946% and 0.038%, respectively. The temperature and relative humidity were kept similar to that in the incubator.The eggs were weighed and candled prior to measurements to check for the presence of embryos. Eggs without an embryo were discarded and replaced with eggs of the same age from the same treatment kept in the incubator as reserves. Six eggs from each treatment were placed in the respiration chambers and measured for 3 h from 9:00 to 12:00, followed by another six eggs from the same treatment measured from 13:00 to 16:00. After each measurement, the eggs were put back into the incubator. The procedure was repeated over the following day with the other batch of eggs; thus, a total of 24 eggs were measured from each treatment per breeder strain. All gas exchange and heat production (HP) measurements were standardised to a 50 g egg mass in order to account for differences in weight during each measurement.HP was calculated from O2 consumption and CO2 production in accordance with Brouwer [12]: HP, kJ = 16.18 × O2, mL + 5.02 × CO2, mL.


### 2.3. Nanosolution

Hydrocolloid AgNano solutions were obtained from Nano-Tech (Warsaw, Poland) and were produced by a patented nonexplosive high voltage method (Polish Patent 3883399) from high purity metals (99.9999%) and high purity demineralised water. The concentrations of nanoparticles in the hydrocolloids were 50, 75, and 100 mg/kg AgNano with a particle size ranging from 2 to 35 nm based on TEM evaluations as described by Chwalibog et al. [13].


### 2.4. Yolk and Yolk Sac Sampling

All eggs were weighed at day 1 of incubation to determine the egg weight at setting. Twelve eggs from each breeder strain, representing the average weight of the eggs at set, were selected at day 1 for fresh yolk collection. At 24 h after hatching, 10 chicks from each treatment were euthanised by decapitation and the yolk sac (YS) was removed from the abdominal cavity and then weighed, stored at −20°C and freeze-dried prior to analysis.


### 2.5. Hatchling Measurement

On the day of hatching, newly hatched chicks were kept without feed and water in a temperature-controlled (32°C) brooder box furnished with a heat lamp for 24 h. Chick weight (CW;n=10) was measured; thereafter, they were euthanized and the liver, heart, and intestine were dissected and weighed.The experimental procedures followed Danish National Legislation.


### 2.6. Analyses

Yolk samples collected at day 1 (n=12) and residual YS at 24 h (n=10) after hatching were analysed in triplicate for the contents of DM and fat. The DM content of wet and freeze-dried yolk was analysed by drying in an oven at 105°C overnight while the fat content was determined using a freeze-dried sample by petroleum ether extraction in a Soxtec system after HCl hydrolysis. The nitrogen (N) content was not considered for analysis because N in yolk could not be determined accurately due to infiltration of protein and water from the nonyolk egg compartments, as reported by Yadgary et al. [10].


### 2.7. Calculations

Yolk-free body weight (YFBW) was determined as the difference between CW and the residual YS. Liver, heart, and intestine weights relative to YFBW (as % of YFBW) were used to calculate relative organ weights (g of organ weight/g of YFBW) × 100. The absolute weights of the YS, yolk fat content (YF), and fat uptake (FU) and their weights relative to YFBW (as % of YFBW) were both calculated, and in case the trend is the same, only the absolute values are shown.YF at day 1 (YFd1) was determined by multiplying the concentration of fat in the yolk with the weight of yolk at day 1. YF at 24 h after hatching (YF24h) was calculated by multiplying the concentration of fat in the YS with the weight of the residual YS 24 h after hatching. FU was determined by calculating the difference in fat contents between the two time points (FU = YFd1−YF24h).


### 2.8. Statistical Analysis

Data were analysed using the GLM procedure of SAS (SAS Institute Inc., 2009) considering the main effects of treatments (50, 75, and 100 mg/kg AgNano), breeder strain (Ross or Lohmann), and the interactions between these variables. The Tukey-Kramer honestly significant difference test was used to test the separation of the means at a significance level ofP<0.05. Data from the placebo group were omitted from analysis due to a technical problem that caused the death of the embryos in this group.


## 2.1. Experimental Design

A 2 × 3 factorial experiment with two breeder strains (Ross × Ross 308 and Lohmann) and three AgNano concentrations (50, 75 and 100 mg/kg) was used.584 fertile chicken eggs from Lohmann (layer-type) and Ross × Ross 308 (broiler-type) breeder strains of the same age (37 weeks old) were obtained from a commercial hatchery. In each breeder strain, 292 eggs were randomly grouped into two batches and stored in a refrigerator (10°C) for 1–3 days before being placed in the incubator. In each batch, 140 eggs were distributed into 5 treatment groups, with 28 eggs per treatment from which 12 eggs from each treatment were used for the measurement of O2 consumption and CO2 production, 5 eggs for the evaluation of hatchling development, and the rest were used as reserves. In addition, 12 eggs per breeder strain were opened at day 1 and the yolk samples were collected. At day 1 of incubation, the eggs from the first batch were numbered and injected according to the following treatment descriptions: (1) control (no injection), (2) sham control (placebo), (3) 50 mg AgNano/kg, (4) 75 mg AgNano/kg, and (5) 100 mg AgNano/kg. The eggs were injected with 0.3 mL of a hydrocolloidal AgNano and phosphate buffered saline solution (placebo) into the air sac using a sterile 27 gauge, 20 mm needle. Immediately after injection, the hole was sealed with hypoallergenic tape and the eggs were placed into an incubator. The eggs were incubated for 21 days under standard conditions (temperature 37.8°C, 55% humidity, eggs turned once per hour for the first 18 days, and temperature 37°C, and 60% humidity from day 19 until hatching). The same procedure was repeated for the eggs in batch 2 on the following day.


## 2.2. Gas Exchange Measurement

The O2 consumption and CO2 production were measured at day 10, 13, 16, and 19 of incubation, according to the procedure described by Chwalibog et al. [11]. Gas exchange measurement was based on the paramagnetic principle in an open air circuit respiration unit (Micro-Oxymax calorimeter from Columbus Instruments, Columbus, OH, USA), equipped with four respiration chambers with a volume of 2000 cm3. The concentrations of O2 and CO2 in the incoming atmospheric air to the chambers were 20.946% and 0.038%, respectively. The temperature and relative humidity were kept similar to that in the incubator.The eggs were weighed and candled prior to measurements to check for the presence of embryos. Eggs without an embryo were discarded and replaced with eggs of the same age from the same treatment kept in the incubator as reserves. Six eggs from each treatment were placed in the respiration chambers and measured for 3 h from 9:00 to 12:00, followed by another six eggs from the same treatment measured from 13:00 to 16:00. After each measurement, the eggs were put back into the incubator. The procedure was repeated over the following day with the other batch of eggs; thus, a total of 24 eggs were measured from each treatment per breeder strain. All gas exchange and heat production (HP) measurements were standardised to a 50 g egg mass in order to account for differences in weight during each measurement.HP was calculated from O2 consumption and CO2 production in accordance with Brouwer [12]: HP, kJ = 16.18 × O2, mL + 5.02 × CO2, mL.


## 2.3. Nanosolution

Hydrocolloid AgNano solutions were obtained from Nano-Tech (Warsaw, Poland) and were produced by a patented nonexplosive high voltage method (Polish Patent 3883399) from high purity metals (99.9999%) and high purity demineralised water. The concentrations of nanoparticles in the hydrocolloids were 50, 75, and 100 mg/kg AgNano with a particle size ranging from 2 to 35 nm based on TEM evaluations as described by Chwalibog et al. [13].


## 2.4. Yolk and Yolk Sac Sampling

All eggs were weighed at day 1 of incubation to determine the egg weight at setting. Twelve eggs from each breeder strain, representing the average weight of the eggs at set, were selected at day 1 for fresh yolk collection. At 24 h after hatching, 10 chicks from each treatment were euthanised by decapitation and the yolk sac (YS) was removed from the abdominal cavity and then weighed, stored at −20°C and freeze-dried prior to analysis.


## 2.5. Hatchling Measurement

On the day of hatching, newly hatched chicks were kept without feed and water in a temperature-controlled (32°C) brooder box furnished with a heat lamp for 24 h. Chick weight (CW;n=10) was measured; thereafter, they were euthanized and the liver, heart, and intestine were dissected and weighed.The experimental procedures followed Danish National Legislation.


## 2.6. Analyses

Yolk samples collected at day 1 (n=12) and residual YS at 24 h (n=10) after hatching were analysed in triplicate for the contents of DM and fat. The DM content of wet and freeze-dried yolk was analysed by drying in an oven at 105°C overnight while the fat content was determined using a freeze-dried sample by petroleum ether extraction in a Soxtec system after HCl hydrolysis. The nitrogen (N) content was not considered for analysis because N in yolk could not be determined accurately due to infiltration of protein and water from the nonyolk egg compartments, as reported by Yadgary et al. [10].


## 2.7. Calculations

Yolk-free body weight (YFBW) was determined as the difference between CW and the residual YS. Liver, heart, and intestine weights relative to YFBW (as % of YFBW) were used to calculate relative organ weights (g of organ weight/g of YFBW) × 100. The absolute weights of the YS, yolk fat content (YF), and fat uptake (FU) and their weights relative to YFBW (as % of YFBW) were both calculated, and in case the trend is the same, only the absolute values are shown.YF at day 1 (YFd1) was determined by multiplying the concentration of fat in the yolk with the weight of yolk at day 1. YF at 24 h after hatching (YF24h) was calculated by multiplying the concentration of fat in the YS with the weight of the residual YS 24 h after hatching. FU was determined by calculating the difference in fat contents between the two time points (FU = YFd1−YF24h).


## 2.8. Statistical Analysis

Data were analysed using the GLM procedure of SAS (SAS Institute Inc., 2009) considering the main effects of treatments (50, 75, and 100 mg/kg AgNano), breeder strain (Ross or Lohmann), and the interactions between these variables. The Tukey-Kramer honestly significant difference test was used to test the separation of the means at a significance level ofP<0.05. Data from the placebo group were omitted from analysis due to a technical problem that caused the death of the embryos in this group.


## 3. Results

### 3.1. Yolk Sac Weight, Fat Content, and Fat Uptake

The residual YS weight was larger in hatchlings treated with AgNano (P=0.001; Figure 1(a)). At 24 h after hatching, no differences were observed among the AgNano concentrations; however, compared with the control, hatchlings treated with 50 and 100 mg AgNano/kg had larger residual YS. The YS weight of hatchlings treated with 75 mg AgNano/kg was intermediate.Comparison of (a) yolk sac weight (YS), (b) yolk fat content (YF),  (c) fat uptake (FU), and (d) yolk-free body weight (YFBW) of hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no injection) at 24 h after hatching. Mean values and standard errors of 4 treatments, each containing 10 chicks.a,b,cSignificant difference (P<0.05) between treatments.
(a)
(b)
(c)
(d)The residual YS of hatchlings treated with 100 mg AgNano/kg contained more fat (P<0.0001; Figure 1(b)) compared with the hatchlings treated with 75 mg AgNano/kg and the control (no injection) group, but was not different from the hatchlings treated with 50 mg AgNano/kg, which had a comparable YF with all treatments. The FU of hatchlings treated with 50 and 100 mg AgNano/kg was the same, but it was lower compared with the hatchlings in the control (no injection) group (P<0.0001; Figure 1(c)). The FU of hatchlings treated with 75 mg AgNano/kg was comparable with the FU of hatchlings treated with 50 mg AgNano/kg and control, but it was higher than the hatchlings treated with 100 mg AgNano/kg (P<0.0001; Figure 1(c)).Fresh yolk weight (18.6 versus 15.8 g) was larger in broiler eggs at day 1 of incubation compared with layer eggs. Expectedly, the YF content (5.97 versus 4.82 g) was also higher in broiler than in layer eggs. The weight of residual YS was 0.37 g higher (P<0.0001; Figure 2(a)) and the amount of YF was 0.59 g higher (P<0.0001; Figure 2(b)) in broiler than in layer hatchlings. The FU was 0.4 g higher in broiler compared with layer hatchlings (P<0.0001; Figure 2(c)).Comparison of (a) yolk sac weight (YS), (b) yolk fat content (YF),  (c) fat uptake (FU), and (d) yolk-free body weight (YFBW) of Ross (broiler-type) and Lohmann (layer-type) hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no injection) at 24 h after hatching. Mean values and standard errors of 4 treatments, each containing 10 chicks.a,bSignificant difference (P<0.05) between treatments.
(a)
(b)
(c)
(d)There was no significant interaction effect between treatment and breeder strain on the YS, YF, and FU (data not shown).


### 3.2. Chick Weight and Organ Weights

AgNano concentrations did not affect egg weight at setting (60.7±0.33), YFBW or the relative weights of the intestine, heart, and liver (% of YFBW) compared with the control (all P>0.05; data not shown).The weight of eggs at setting was 5% heavier in broilers than in layers (63.0 versus 60.0;P<0.0001). The YFBW of broiler hatchlings was 13% heavier than in layer hatchlings (P<0.0001; Figure 2(d)). Except for the relative weight of the intestine, no effect was noted on other organ weights. The relative weight of the intestine in broilers was 8% heavier than in layer hatchlings (5.0 versus 4.6%; P<0.0001). The relative heart and liver weights did not differ between breeder strains (P>0.05; data not shown).No interaction effect was noted between treatment and breeder strain on YFBW and the relative weights of intestine, liver, and heart (P>0.05; data not shown).


### 3.3. Metabolic Rate

An effect of treatment and breeder strain was observed on gas exchange and HP. The hatchlings treated with 50 and 100 mg AgNano/kg had the lowest metabolic rate (O2 consumption, CO2 production, and HP) during incubation (P<0.001; Table 1).Table 1
Total oxygen consumption (O2), carbon dioxide production (CO2), and heat production (HP) of layer (Lohmann-Lo) and broiler (Ross-Ro) hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no-injection, C) measured at embryonic days  13 to 191.
O2  mL∗h−1
CO2  mL∗h−1
HPJ∗h−1
Treatment
100
13.2a
8.4a
255a
75
13.7b
8.9b
267b
50
13.2a
8.3a
255a
C
14.3b
9.3b
279b
Breeder strain
Lohmann
12.7a
8.0a
245a
Ross
14.6b
9.6b
284b
SE2
0.121
0.124
2.45
P value
Treatment
0.001
<0.0001
<0.0001
Breeder strain
<0.0001
<0.0001
<0.0001
Treatment× strain
0.64
0.06
0.06
Within columns: means with different superscripts differed significantly (P<0.05).
1Mean values of 4 treatments, each containing 24 embryos per breeder strain.
2Pooled standard error.Broiler embryos consumed 13% more O2, produced 17% more CO2, and expended 14% more heat compared with layer embryos (P<0.001; Table 1).There was no interaction effect recorded between treatment and breeder strain on the metabolic rate (P>0.05; data not shown).


## 3.1. Yolk Sac Weight, Fat Content, and Fat Uptake

The residual YS weight was larger in hatchlings treated with AgNano (P=0.001; Figure 1(a)). At 24 h after hatching, no differences were observed among the AgNano concentrations; however, compared with the control, hatchlings treated with 50 and 100 mg AgNano/kg had larger residual YS. The YS weight of hatchlings treated with 75 mg AgNano/kg was intermediate.Comparison of (a) yolk sac weight (YS), (b) yolk fat content (YF),  (c) fat uptake (FU), and (d) yolk-free body weight (YFBW) of hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no injection) at 24 h after hatching. Mean values and standard errors of 4 treatments, each containing 10 chicks.a,b,cSignificant difference (P<0.05) between treatments.
(a)
(b)
(c)
(d)The residual YS of hatchlings treated with 100 mg AgNano/kg contained more fat (P<0.0001; Figure 1(b)) compared with the hatchlings treated with 75 mg AgNano/kg and the control (no injection) group, but was not different from the hatchlings treated with 50 mg AgNano/kg, which had a comparable YF with all treatments. The FU of hatchlings treated with 50 and 100 mg AgNano/kg was the same, but it was lower compared with the hatchlings in the control (no injection) group (P<0.0001; Figure 1(c)). The FU of hatchlings treated with 75 mg AgNano/kg was comparable with the FU of hatchlings treated with 50 mg AgNano/kg and control, but it was higher than the hatchlings treated with 100 mg AgNano/kg (P<0.0001; Figure 1(c)).Fresh yolk weight (18.6 versus 15.8 g) was larger in broiler eggs at day 1 of incubation compared with layer eggs. Expectedly, the YF content (5.97 versus 4.82 g) was also higher in broiler than in layer eggs. The weight of residual YS was 0.37 g higher (P<0.0001; Figure 2(a)) and the amount of YF was 0.59 g higher (P<0.0001; Figure 2(b)) in broiler than in layer hatchlings. The FU was 0.4 g higher in broiler compared with layer hatchlings (P<0.0001; Figure 2(c)).Comparison of (a) yolk sac weight (YS), (b) yolk fat content (YF),  (c) fat uptake (FU), and (d) yolk-free body weight (YFBW) of Ross (broiler-type) and Lohmann (layer-type) hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no injection) at 24 h after hatching. Mean values and standard errors of 4 treatments, each containing 10 chicks.a,bSignificant difference (P<0.05) between treatments.
(a)
(b)
(c)
(d)There was no significant interaction effect between treatment and breeder strain on the YS, YF, and FU (data not shown).


## 3.2. Chick Weight and Organ Weights

AgNano concentrations did not affect egg weight at setting (60.7±0.33), YFBW or the relative weights of the intestine, heart, and liver (% of YFBW) compared with the control (all P>0.05; data not shown).The weight of eggs at setting was 5% heavier in broilers than in layers (63.0 versus 60.0;P<0.0001). The YFBW of broiler hatchlings was 13% heavier than in layer hatchlings (P<0.0001; Figure 2(d)). Except for the relative weight of the intestine, no effect was noted on other organ weights. The relative weight of the intestine in broilers was 8% heavier than in layer hatchlings (5.0 versus 4.6%; P<0.0001). The relative heart and liver weights did not differ between breeder strains (P>0.05; data not shown).No interaction effect was noted between treatment and breeder strain on YFBW and the relative weights of intestine, liver, and heart (P>0.05; data not shown).


## 3.3. Metabolic Rate

An effect of treatment and breeder strain was observed on gas exchange and HP. The hatchlings treated with 50 and 100 mg AgNano/kg had the lowest metabolic rate (O2 consumption, CO2 production, and HP) during incubation (P<0.001; Table 1).Table 1
Total oxygen consumption (O2), carbon dioxide production (CO2), and heat production (HP) of layer (Lohmann-Lo) and broiler (Ross-Ro) hatchlings in ovo injected with different concentrations of AgNano (50, 75, and 100 mg/kg) and the control (no-injection, C) measured at embryonic days  13 to 191.
O2  mL∗h−1
CO2  mL∗h−1
HPJ∗h−1
Treatment
100
13.2a
8.4a
255a
75
13.7b
8.9b
267b
50
13.2a
8.3a
255a
C
14.3b
9.3b
279b
Breeder strain
Lohmann
12.7a
8.0a
245a
Ross
14.6b
9.6b
284b
SE2
0.121
0.124
2.45
P value
Treatment
0.001
<0.0001
<0.0001
Breeder strain
<0.0001
<0.0001
<0.0001
Treatment× strain
0.64
0.06
0.06
Within columns: means with different superscripts differed significantly (P<0.05).
1Mean values of 4 treatments, each containing 24 embryos per breeder strain.
2Pooled standard error.Broiler embryos consumed 13% more O2, produced 17% more CO2, and expended 14% more heat compared with layer embryos (P<0.001; Table 1).There was no interaction effect recorded between treatment and breeder strain on the metabolic rate (P>0.05; data not shown).


## 4. Discussion

### 4.1. Fat Uptake

This study revealed that AgNano reduced FU, indicating a reduction in fat oxidation, as demonstrated by higher weights of the YS and YF 24 h after hatching. The results are unexpected and contrary to our hypothesis that AgNano, as carrier of available O2 with high surface reactivity, would increase O2 consumption and accelerate fat oxidation. In the current study, we demonstrated that FU was lower in hatchlings treated with 50 and 100 mg AgNano/kg, but surprisingly not in hatchlings treated with 75 mg AgNano/kg, which suggested that the pattern of oxidation did not respond linearly to the increase in AgNano concentration. The reason for this response is unknown, but perhaps the rates of O2 consumption could explain this pattern of fat oxidation. O2 supply is essential for the β-oxidation of fatty acids from the yolk and effective retrieval of lipids during incubation, as pointed out in several reviews [1–4] and demonstrated in previous study that the rate of O2 consumption influences the amount of yolk fat used [14]. Further, O2 consumption and FU are positively correlated as documented in several studies [9, 11], which showed that a lower O2 consumption rate and higher yolk weight are associated with less fat oxidation. In our study, this positive relationship between O2 consumption and FU was documented; hatchlings treated with 50 and 100 mg AgNano/kg exhibited lower rates of O2 consumption which explains the lower FU.Several studies have demonstrated that at hatching, the weights of the residual YS, YF, and FU are higher in broiler compared to layer hatchlings because of the higher metabolic rate in the former, which favours the oxidation of fat and explains the higher rates of fat consumption [8, 9, 15]. In the present study, similar results were documented in broiler hatchlings for the same parameters. Apart from the difference in metabolic rates, we also attributed the increase in these parameters to the bigger size of eggs and yolks in broilers that contain more fat and possibly other nutrients, being responsible for the larger weight of the YS and higher YF content in broiler hatchlings [14, 16].No significant interaction effect between treatments and breeder strain was noted on YS, YF, and FU of hatchlings. This can be explained by the lack of an interaction effect on the metabolic rate exhibited by both breeder strains in response to AgNano treatments.


### 4.2. Metabolic Rate

In comparison with the control (no injection) group, a negative effect on the metabolic rate was recorded in hatchlings injected with 50 and 100 mg AgNano/kg. This finding is contrary to our previous work [7] and the reason for this is unknown. It is probable that the AgNano concentration of 50 mg/kg is too low and 100 mg AgNano/kg is too high to increase the metabolic rate. It is apparent from the present results that the metabolic rate of hatchlings treated with 75 mg AgNano/kg was higher than with 50 and 100 mg AgNano/kg but comparable with the control (no injection) group, suggesting that the optimum concentration that would increase the metabolic rate is within the range of 50–100 mg/kg, but this remains to be elucidated.In agreement with other studies [7, 9, 17–19], our work documented that the metabolic rate of broiler embryos was higher compared with layer embryos.The lack of a significant interaction effect between the treatment and breeder strain on the metabolic rate was not in complete agreement with our previous study. In conformity with previous experiments [7, 20], the metabolic rate of broiler embryos was not affected by AgNano treatment, probably because of genetically programmed maxima. However, the lack of an effect in layers is a contrasting result, as we have previously recorded a significant increase in O2 consumption in layer embryos injected with 50 mg AgNano/kg. The difference between studies could be caused by differences in egg shell conductance and porosity between the breeder flock used, possibly as an effect of age. The metabolic rate of layer embryos from the older breeder flock used in the previous study was 30% lower than in embryos produced by the peak breeder flock used in the current work (9 mL*h−1  versus 13 mL*h−1) [7]. It has previously been reported that egg shell conductance and porosity decrease as a breeder flock ages [21]. If this is the case, it can be speculated that the decrease in shell porosity possibly reduced the O2 diffusion capacity of the shell pore system and the resultant hypoxia limited metabolism in the old breeder flock [5]. The findings of our studies may suggest that the effect of AgNano on metabolic rate is influenced not only by strain, but also by the rate of O2 consumption of the embryo. It seems that AgNano exert most of their effect on the metabolic rate of layer embryos with less porous shells and a limited supply of O2. These assumptions, however, need to be confirmed in further research since we did not assess shell conductance and porosity in either of the studies conducted.


### 4.3. Hatchling Development

In the current study, the YFBW and relative organ weights of chicks were used as an indicator of hatchling development. The YFBW was higher for broiler than for layer hatchlings, which is in agreement with the documented higher BW and faster development in broiler versus layer chicken embryos reported previously [7, 9, 17, 22]. The difference in hatchling development in the present study could be associated primarily with differences in genetic background between breeder strains [19], the pattern of fat utilisation [8, 9], and egg size [16].The present results also demonstrate a difference in the relative intestine weight between breeder strains. We recorded a higher relative weight of the intestine in broiler compared to layer hatchlings, which may indicate more advanced maturation of the intestine in broiler hatchlings [22]. A probable reason could be that the broiler chickens have a short production period and it is important that the intestine reaches its functional capacity as early as possible to enhance digestion of nutrients and growth [3, 15].Hatchling development was not affected by the AgNano concentration. This lack of treatment effect is consistent with findings in quail, pigs, and chickens and supports the conclusion that AgNano do not affect growth [7, 20, 23–25]. Interestingly, the difference in fat uptake between treatments was not reflected in hatchling development. The development of hatchlings treated with 50 and 100 mg AgNano/kg was maintained with minimal consumption of YF, which may suggest that other nutrients were utilized [10], or it could be that the difference in FU was too small to elicit an effect on growth. It is also probable that the period of observation was too short (24 h) for the difference to be determined. It has previously been shown that the effect of dietary fat on the growth of neonatal broiler chickens is greatest at 10 days of age [26].


## 4.1. Fat Uptake

This study revealed that AgNano reduced FU, indicating a reduction in fat oxidation, as demonstrated by higher weights of the YS and YF 24 h after hatching. The results are unexpected and contrary to our hypothesis that AgNano, as carrier of available O2 with high surface reactivity, would increase O2 consumption and accelerate fat oxidation. In the current study, we demonstrated that FU was lower in hatchlings treated with 50 and 100 mg AgNano/kg, but surprisingly not in hatchlings treated with 75 mg AgNano/kg, which suggested that the pattern of oxidation did not respond linearly to the increase in AgNano concentration. The reason for this response is unknown, but perhaps the rates of O2 consumption could explain this pattern of fat oxidation. O2 supply is essential for the β-oxidation of fatty acids from the yolk and effective retrieval of lipids during incubation, as pointed out in several reviews [1–4] and demonstrated in previous study that the rate of O2 consumption influences the amount of yolk fat used [14]. Further, O2 consumption and FU are positively correlated as documented in several studies [9, 11], which showed that a lower O2 consumption rate and higher yolk weight are associated with less fat oxidation. In our study, this positive relationship between O2 consumption and FU was documented; hatchlings treated with 50 and 100 mg AgNano/kg exhibited lower rates of O2 consumption which explains the lower FU.Several studies have demonstrated that at hatching, the weights of the residual YS, YF, and FU are higher in broiler compared to layer hatchlings because of the higher metabolic rate in the former, which favours the oxidation of fat and explains the higher rates of fat consumption [8, 9, 15]. In the present study, similar results were documented in broiler hatchlings for the same parameters. Apart from the difference in metabolic rates, we also attributed the increase in these parameters to the bigger size of eggs and yolks in broilers that contain more fat and possibly other nutrients, being responsible for the larger weight of the YS and higher YF content in broiler hatchlings [14, 16].No significant interaction effect between treatments and breeder strain was noted on YS, YF, and FU of hatchlings. This can be explained by the lack of an interaction effect on the metabolic rate exhibited by both breeder strains in response to AgNano treatments.


## 4.2. Metabolic Rate

In comparison with the control (no injection) group, a negative effect on the metabolic rate was recorded in hatchlings injected with 50 and 100 mg AgNano/kg. This finding is contrary to our previous work [7] and the reason for this is unknown. It is probable that the AgNano concentration of 50 mg/kg is too low and 100 mg AgNano/kg is too high to increase the metabolic rate. It is apparent from the present results that the metabolic rate of hatchlings treated with 75 mg AgNano/kg was higher than with 50 and 100 mg AgNano/kg but comparable with the control (no injection) group, suggesting that the optimum concentration that would increase the metabolic rate is within the range of 50–100 mg/kg, but this remains to be elucidated.In agreement with other studies [7, 9, 17–19], our work documented that the metabolic rate of broiler embryos was higher compared with layer embryos.The lack of a significant interaction effect between the treatment and breeder strain on the metabolic rate was not in complete agreement with our previous study. In conformity with previous experiments [7, 20], the metabolic rate of broiler embryos was not affected by AgNano treatment, probably because of genetically programmed maxima. However, the lack of an effect in layers is a contrasting result, as we have previously recorded a significant increase in O2 consumption in layer embryos injected with 50 mg AgNano/kg. The difference between studies could be caused by differences in egg shell conductance and porosity between the breeder flock used, possibly as an effect of age. The metabolic rate of layer embryos from the older breeder flock used in the previous study was 30% lower than in embryos produced by the peak breeder flock used in the current work (9 mL*h−1  versus 13 mL*h−1) [7]. It has previously been reported that egg shell conductance and porosity decrease as a breeder flock ages [21]. If this is the case, it can be speculated that the decrease in shell porosity possibly reduced the O2 diffusion capacity of the shell pore system and the resultant hypoxia limited metabolism in the old breeder flock [5]. The findings of our studies may suggest that the effect of AgNano on metabolic rate is influenced not only by strain, but also by the rate of O2 consumption of the embryo. It seems that AgNano exert most of their effect on the metabolic rate of layer embryos with less porous shells and a limited supply of O2. These assumptions, however, need to be confirmed in further research since we did not assess shell conductance and porosity in either of the studies conducted.


## 4.3. Hatchling Development

In the current study, the YFBW and relative organ weights of chicks were used as an indicator of hatchling development. The YFBW was higher for broiler than for layer hatchlings, which is in agreement with the documented higher BW and faster development in broiler versus layer chicken embryos reported previously [7, 9, 17, 22]. The difference in hatchling development in the present study could be associated primarily with differences in genetic background between breeder strains [19], the pattern of fat utilisation [8, 9], and egg size [16].The present results also demonstrate a difference in the relative intestine weight between breeder strains. We recorded a higher relative weight of the intestine in broiler compared to layer hatchlings, which may indicate more advanced maturation of the intestine in broiler hatchlings [22]. A probable reason could be that the broiler chickens have a short production period and it is important that the intestine reaches its functional capacity as early as possible to enhance digestion of nutrients and growth [3, 15].Hatchling development was not affected by the AgNano concentration. This lack of treatment effect is consistent with findings in quail, pigs, and chickens and supports the conclusion that AgNano do not affect growth [7, 20, 23–25]. Interestingly, the difference in fat uptake between treatments was not reflected in hatchling development. The development of hatchlings treated with 50 and 100 mg AgNano/kg was maintained with minimal consumption of YF, which may suggest that other nutrients were utilized [10], or it could be that the difference in FU was too small to elicit an effect on growth. It is also probable that the period of observation was too short (24 h) for the difference to be determined. It has previously been shown that the effect of dietary fat on the growth of neonatal broiler chickens is greatest at 10 days of age [26].


## 5. Conclusion

The results demonstrate that AgNano at 50 and 100 mg/kg affected the metabolic rate and fat uptake; however, it did not influence the development of hatchlings. In ovo injection of AgNano at 50 and 100 mg/kg reduces the need to use yolk fat as an energy source, and it can be speculated that the remaining fat in the residual YS can be a potent source of posthatching nutritional reserves for hatchlings. However, further investigation is necessary to establish its potential.



---

*Source: 212486-2012-09-29.xml*